ArticleNephron2026

Long-Term Therapy with Eculizumab Biosimilar in Patients with Atypical Haemolytic Uraemic Syndrome: Outcomes of a Prospective Observational Study.

Oleg Kotenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.